According to Bernstein analysts, while Robinhood (NASDAQ:)’s rise in 2021 was tied to the Zero Interest Rate Policy (ZIRP), the platform is now benefiting from a “Peak Interest Rate Policy” (PIRP) as rates start to decline. “HOOD has not just survived a winter, and is now evolving to be a sustainable business with improving economics,” said the firm in a note Thursday. Robinhood stock has surged approximately 30% in the past month and nearly 100% year-to-date. Bernstein highlights five key reasons behind Robinhood’s recent breakout. Growing Assets, Not Just Trading Revenues: Robinhood’s assets under custody have grown to $140 billion, up…
Author: user
Exchange-traded funds can prove useful for exposure to specific sectors or international indices, for example. Read on to find out the names of five that a handful of our free-site writers hold in their Stocks and Shares ISAs… Invesco EQQQ Nasdaq 100 What it does: This ETF tracks the Nasdaq 100 index, which represents the largest 100 non-financial companies on the Nasdaq Stock Exchange. By Harshil Patel. The Invesco EQQQ Nasdaq 100 ETF (LSE:EQQQ) might sound like a mouthful, but it offers a simple way to own the largest growth shares. In fact, it’s one of the largest individual holdings in my Stocks…
Citi has reaffirmed its Buy rating and a $342.00 price target for Alnylam Pharmaceuticals (NASDAQ: ALNY). The endorsement comes after Alnylam’s recent TTR Investor Day, which focused on the challenges and treatment needs associated with transthyretin amyloid cardiomyopathy (ATTR-CM). The company’s event highlighted the disease’s severity and the growing demand for effective treatments in a competitive market. Alnylam’s positive momentum is partly due to the encouraging HELIOS-B study results for Amvuttra in treating ATTR-CM, released earlier this year. These findings have positioned Amvuttra to potentially become the first-line, standard care in what is anticipated to be a highly lucrative market.…
The finance community has invested much effort to identify new factors that may indicate a security’s forward-looking performance or a portfolio’s risk attributes. While this research can help us better understand asset pricing and offer the possibility of better performance, too often it presumes continuous markets, free trading, and boundless liquidity. Far less research has focused on the practitioner’s dilemma: implementation shortfalls caused by frictions like trading costs and discontinuous trading. These real-life frictions can erode the performance of smart beta and factor strategies. Along with asset management fees, they are the main sources of the sometimes-vast gap between live…
Die September-Euphorie am Krypto-Markt ist verflogen, die Währungen zeigen sich wieder schwächer. Dabei sprechen niedrigere Zinsen, die Etablierung der Anlageklasse und die Saisonalität für die Coins, wie viele meinen.10. Oktober 2024. FRANKFURT (Börse Frankfurt). Nach dem kräftigen Anstieg von Bitcoin & Co. im September hat der Oktober für etwas Ernüchterung in der Krypto-Szene gesorgt. „Aufgrund der Eskalation der geopolitischen Spannungen im Nahen Osten kam es zu einem vorläufigen Ende des Aufschwungs“, berichtet André Dragosch von der ETC Group. Dazu kommen Spekulationen, dass die US-Regierung knapp 70.000 Bitcoins verkaufen könnte, die beim Betreiber des Darkweb-Marktplatzes Silk Road beschlagnahmt wurden. Der Verkauf von…
A look at the day ahead in U.S. and global markets from Mike DolanWith U.S. stocks at new records and devastating Hurricane Milton now weakening as it passes over Florida, the shifting U.S. interest rate horizon is back in focus with September’s key inflation update due on Thursday.Despite the stormy weather and Middle East anxiety, U.S. economic soundings remain robust and Federal Reserve easing expectations continue to be dialled back – sending the dollar to near two month highs in the process.With the U.S. economy estimated to be still expanding at more than 3%, markets now seeing little more than…
Image source: Getty Images The performance of the S&P 500 in the last five years has been nothing short of stunning. If I’d put every penny of £10,000 in a tracker fund back in 2019, I’d now have somewhere around £19,500. Throwing the same amount at the FTSE 100 would have left me with about £11,350. Even though I’m not taking into account dividends or fees here, that’s still an almighty difference. But since we know what goes up can always come down, would it be madness for me to be stay bullish on the US index today? Is the…
In the vicinity of Manila, a coal-fired power plant hopes to become a model for developing countries striving to abandon this polluting fossil fuel. An alliance led by the Rockefeller Foundation, a philanthropic group, plans to help close this plant ten years earlier than scheduled, avoiding millions of tons of emissions by monetizing them as carbon credits. “The idea is ‘pretty simple’,” explains Joseph Curtin, general director of Rockefeller’s energy and climate team, to AFP. “What if, instead of selling this high-carbon energy to the electrical grid, the coal owner could sell the avoided carbon emissions?” Essentially, carbon credits allow…
A look at the day ahead in U.S. and global markets from Mike Dolan With U.S. stocks at new records and devastating Hurricane Milton now weakening as it passes over Florida, the shifting U.S. interest rate horizon is back in focus with September’s key inflation update due on Thursday. Despite the stormy weather and Middle East anxiety, U.S. economic soundings remain robust and Federal Reserve easing expectations continue to be dialled back – sending the dollar to near two month highs in the process. With the U.S. economy estimated to be still expanding at more than 3%, markets now seeing…
(This is CNBC Pro’s live coverage of Thursday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) A pharmacy operator and an industrial stock were among the stocks being talked by analysts on Thursday. Barclays upgraded CVS to overweight from equal weight, calling for 24% upside. Meanwhile, JPMorgan lowered its rating on Honeywell International to neutral from overweight. Check out the latest calls and chatter below. All times ET. 5:50 a.m.: Barclays upgrades CVS, sees 24% upside Barclays sees significant upside ahead for shares of CVS . The bank upgraded the pharmaceutical stock…